Leggett & Platt, Incorporated designs, manufactures, and sells engineered components and products in the United States, Europe, China, Canada, Mexico, and internationally. The company offers steel rod, drawn wire, innersprings, specialty foam chemicals and additives, for use in bedding and furniture, semi-finished mattresses, private label finished mattresses, pillows and toppers, static foundations, adjustable beds, machines to produce innersprings, industrial sewing and quilting machines, and mattress-packaging and glue-drying equipment to industrial users of steel rod and wire, manufacturers of finished bedding, bedding brands and mattress retailers, e-commerce retailers, big box retailers, department stores, and home improvement centers. It also provides mechanical and pneumatic lumbar support and massage systems for automotive seating, seat suspension systems, motors and actuators, and cables; titanium, nickel, and stainless-steel tubing, formed tubes, tube assemblies, and flexible joint components for fluid conveyance systems; and engineered hydraulic cylinders to automobile original equipment manufacturers (OEMs) and suppliers, aerospace OEMs and suppliers, and mobile equipment OEMs. In addition, the company offers steel mechanisms and motion hardware; springs and seat suspensions; components and private label finished goods for soft seating; bases, columns, back rests, casters, and frames for office chairs and control devices; and carpet cushion and hard surface flooring underlayment, structural fabrics, and geo components for manufacturers of upholstered and office furniture, flooring retailers and distributors, contractors, landscapers, road construction companies, retailers, government agencies, mattress and furniture producers, and manufacturers of draperies, specialty packaging, filtration, and automotive upholstery. Leggett & Platt, Incorporated was founded in 1883 and is based in Carthage, Missouri.

Leggett & Platt Incorporated

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Toll Brothers (TOL – Research Report) and Leggett & Platt ...

Analysts Conflicted on These Consumer Cyclical Names: Toll Brothers (TOL) and Leggett & Platt (LEG)

Einride AB, a private freight tech company based in Sweden, has shared early results from a planned three-year partnership with IonQ ($IONQ). The t...

IonQ Teams with Einride to Apply Quantum Tech to Freight Ahead of SPAC Listing

In a report released today, Shaun Cousins from UBS maintained a Buy rating on Coles Group, with a price target of A$25.00. Cousins covers the Consu...

UBS Remains a Buy on Coles Group (CLEGF)

Coles Group ( ($AU:COL) ) has shared an announcement. Coles Group Limited announced the issuance of 680,774 performance rights as part of an employ...

Coles Group Issues New Performance Rights Under Employee Incentive Scheme

An announcement from Coles Group ( ($AU:COL) ) is now available. Coles Group Limited announced a change in the director’s interest in securities, s...

Coles Group Announces Director’s Interest Change

Legend Biotech ( ($LEGN) ) just unveiled an update. On December 6, 2025, Legend Biotech announced new data from the CARTITUDE studies at the ASH An...

Legend Biotech Unveils Promising CARVYKTI® Data at ASH 2025

The latest update is out from Legend Mining Limited ( ($AU:LEG) ). Legend Mining Limited has identified two new high priority gold soil anomalies a...

Legend Mining Identifies New Gold Anomalies at Pinnacle Well

Deutsche Bank analyst Thomas Rothausler upgraded LEG Immobilien to a Buy today and set a price target of €78.00. Rothausler covers the Real Estate ...

Positive Report for LEG Immobilien (0QC9) from Deutsche Bank

In a report released on November 27, Thomas Neuhold from Kepler Capital maintained a Buy rating on LEG Immobilien, with a price target of €112.00. ...

Kepler Capital  Sticks to Its Buy Rating for LEG Immobilien (0QC9)

In a report released on November 12, Thomas Neuhold from Kepler Capital maintained a Buy rating on LEG Immobilien, with a price target of €112.00. ...

Kepler Capital  Remains a Buy on LEG Immobilien (0QC9)

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Legend Biotech, with a price target of $83.00. According t...

Current Quarter	$0.22	Next Quarter	$0.25
Current Year	$1.04	Next Year	$1.07
QoQ Growth	+13.6%	YoY Growth	+2.9%
3Y EPS CAGR	-48.3%	Target Price	$11.00
Consensus	Buy	Upside	-5.1%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LEG	$11.59	-1.36%	2.13M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LEG	$11.59	-1.4%	2.13M
3
4
5
6

LEG

LEG

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Leggett & Platt Incorporated Data in Excel

Get Leggett & Platt Incorporated Data in Excel